Labeler
Accord Healthcare Inc. NDC Codes
Accord Healthcare Inc. lists 227 finished drug products in the FDA NDC Directory under NDC labeler code 16729.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine sodium, Lenalidomide, lurasidone hydrochloride, Hydroxychloroquine Sulfate, Glycopyrrolate, Tadalafil, Vilazodone Hydrochloride, Pemetrexed, Atropine Sulfate, Furosemide, Methylphenidate Hydrochloride, Olmesartan Medoxomil And Hydrochlorothiazide, Diltiazem Hydrochloride, Dofetilide, Cinacalcet
- Active ingredients
- Levothyroxine sodium, Lenalidomide, Lurasidone hydrochloride, Hydroxychloroquine sulfate, Glycopyrrolate, Tadalafil, Vilazodone hydrochloride, Pemetrexed disodium hemipentahydrate, Atropine sulfate, Furosemide, Methylphenidate hydrochloride, Olmesartan medoxomil
- NDC labeler codes
- 16729
- Strengths (from the 100 most recently listed products)
- Glycopyrrolate .2 mg/mL; Furosemide 10 mg/mL; Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Lenalidomide 2.5 mg/1; Lenalidomide 25 mg/1; Lenalidomide 15 mg/1; Lenalidomide 5 mg/1; Lenalidomide 20 mg/1; Lenalidomide 10 mg/1; Clomiphene citrate 50 mg/1; Alcohol 1 mL/mL; Teriflunomide 7 mg/1; Teriflunomide 14 mg/1; Regadenoson .08 mg/mL; Lurasidone hydrochloride 20 mg/1; Lurasidone hydrochloride 40 mg/1; Lurasidone hydrochloride 60 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Capsule, Injection, Powder, Lyophilized, For solution, Injection, Solution, Tablet, Extended release, Capsule, Extended release, Capsule, Delayed release, Ointment, Cream
- Routes
- Oral, Intravenous, Intramuscular, Topical, Subcutaneous, Sublingual, Percutaneous, Endotracheal, Intramedullary
- Drug classes (FDA established)
- l-Thyroxine, Atypical Antipsychotic, Anticholinergic, Cholinergic Muscarinic Antagonist, Thalidomide Analog, Folate Analog Metabolic Inhibitor, Antimalarial, Antirheumatic Agent, Phosphodiesterase 5 Inhibitor, Alkylating Drug, Loop Diuretic, Central Nervous System Stimulant, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Calcium Channel Blocker, Antiarrhythmic, Calcium-sensing Receptor Agonist, Pyrimidine Synthesis Inhibitor, Pyridone, Nucleoside Metabolic Inhibitor, Anti-coagulant, Direct Thrombin Inhibitor, Opioid Antagonist, Partial Opioid Agonist, Lipopeptide Antibacterial, Calcineurin Inhibitor Immunosuppressant, Aminoketone, P2Y12 Platelet Inhibitor, Estrogen Agonist/Antagonist, Pharmacologic Cardiac Stress Test Agent, Sphingosine 1-phosphate Receptor Modulator, Carbonic Anhydrase Inhibitor, Estrogen Receptor Antagonist, Topoisomerase Inhibitor, Dietary Cholesterol Absorption Inhibitor, Serotonin Reuptake Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 137 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| ropinirole | Ropinirole hydrochloride 3 mg/1 | Tablet, Film coatedOral | 16729-236 | 16729-0236-01 | — |
| ropinirole | Ropinirole hydrochloride 4 mg/1 | Tablet, Film coatedOral | 16729-237 | 16729-0237-01 | — |
| ropinirole | Ropinirole hydrochloride 5 mg/1 | Tablet, Film coatedOral | 16729-238 | 16729-0238-01 | — |
| ropinirole | Ropinirole hydrochloride .25 mg/1 | Tablet, Film coatedOral | 16729-232 | 16729-0232-01 | — |
| ropinirole | Ropinirole hydrochloride .5 mg/1 | Tablet, Film coatedOral | 16729-233 | 16729-0233-01 | — |
| ropinirole | Ropinirole hydrochloride 1 mg/1 | Tablet, Film coatedOral | 16729-234 | 16729-0234-01 | — |
| ropinirole | Ropinirole hydrochloride 2 mg/1 | Tablet, Film coatedOral | 16729-235 | 16729-0235-01 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 150 mg/1 | TabletOral | 16729-301 | 16729-0301-0116729-0301-16 | — |
| Eplerenone | Eplerenone 25 mg/1 | Tablet, Film coatedOral | 16729-293 | 16729-0293-1016729-0293-15 | — |
| Eplerenone | Eplerenone 50 mg/1 | Tablet, Film coatedOral | 16729-294 | 16729-0294-1016729-0294-15 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 50 mg/1 | TabletOral | 16729-299 | 16729-0299-0116729-0299-17 | — |
| Trazodone Hydrochloride | Trazodone hydrochloride 100 mg/1 | TabletOral | 16729-300 | 16729-0300-0116729-0300-17 | — |
| Dalfampridine | Dalfampridine 10 mg/1 | Tablet, Film coated, Extended releaseOral | 16729-292 | 16729-0292-12 | — |
| Temsirolimus | — | Kit | 16729-223 | 16729-0223-61 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 20 mg/1 | Tablet, Film coatedOral | 16729-045 | 16729-0045-1516729-0045-17 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 40 mg/1 | Tablet, Film coatedOral | 16729-046 | 16729-0046-1516729-0046-17 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 80 mg/1 | Tablet, Film coatedOral | 16729-047 | 16729-0047-1516729-0047-16 | — |
| Atorvastatin Calcium | Atorvastatin calcium trihydrate 10 mg/1 | Tablet, Film coatedOral | 16729-044 | 16729-0044-1516729-0044-17 | — |
| oxaliplatin | Oxaliplatin 5 mg/mL | Injection, Solution, ConcentrateIntravenous | 16729-332 | 16729-0332-0316729-0332-05 | — |
| olmesartan medoxomil | Olmesartan medoxomil 5 mg/1 | Tablet, Film coatedOral | 16729-320 | 16729-0320-1016729-0320-15 | — |
| Quetiapine Fumarate | Quetiapine fumarate 50 mg/1 | Tablet, Extended releaseOral | 16729-132 | 16729-0132-12 | — |
| Zoledronic acid | Zoledronic acid 4 mg/5mL | InjectionIntravenous | 16729-242 | 16729-0242-31 | — |
| Carboplatin | Carboplatin 10 mg/mL | InjectionIntravenous | 16729-295 | 16729-0295-1216729-0295-3116729-0295-33+1 more | — |
| Mycophenolic Acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 16729-189 | 16729-0189-1616729-0189-29 | — |
| Mycophenolic Acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 16729-261 | 16729-0261-29 | — |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | 16729-415 | 16729-0415-0116729-0415-17 | — |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | 16729-414 | 16729-0414-0116729-0414-17 | — |
| Spironolactone | Spironolactone 25 mg/1 | Tablet, Film coatedOral | 16729-225 | 16729-0225-0116729-0225-1616729-0225-17 | — |
| Spironolactone | Spironolactone 50 mg/1 | Tablet, Film coatedOral | 16729-226 | 16729-0226-0116729-0226-16 | — |
| Spironolactone | Spironolactone 100 mg/1 | Tablet, Film coatedOral | 16729-227 | 16729-0227-0116729-0227-16 | — |
| olmesartan medoxomil | Olmesartan medoxomil 20 mg/1 | Tablet, Film coatedOral | 16729-321 | 16729-0321-1016729-0321-1516729-0321-17 | — |
| olmesartan medoxomil | Olmesartan medoxomil 40 mg/1 | Tablet, Film coatedOral | 16729-322 | 16729-0322-1016729-0322-1516729-0322-17 | — |
| Clozapine | Clozapine 25 mg/1 | TabletOral | 16729-141 | 16729-0141-0116729-0141-16 | — |
| Clozapine | Clozapine 100 mg/1 | TabletOral | 16729-142 | 16729-0142-0116729-0142-16 | — |
| Decitabine | Decitabine 50 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-224 | 16729-0224-05 | — |
| Temozolomide | Temozolomide 5 mg/1 | CapsuleOral | 16729-048 | 16729-0048-5316729-0048-54 | — |
| Temozolomide | Temozolomide 20 mg/1 | CapsuleOral | 16729-049 | 16729-0049-5316729-0049-54 | — |
| Temozolomide | Temozolomide 100 mg/1 | CapsuleOral | 16729-050 | 16729-0050-5316729-0050-54 | — |
| Temozolomide | Temozolomide 250 mg/1 | CapsuleOral | 16729-051 | 16729-0051-53 | — |
| Temozolomide | Temozolomide 140 mg/1 | CapsuleOral | 16729-129 | 16729-0129-5316729-0129-54 | — |
| Temozolomide | Temozolomide 180 mg/1 | CapsuleOral | 16729-130 | 16729-0130-5316729-0130-54 | — |
| Pravastatin Sodium | Pravastatin sodium 10 mg/1 | TabletOral | 16729-008 | 16729-0008-1516729-0008-16 | — |
| Pravastatin Sodium | Pravastatin sodium 20 mg/1 | TabletOral | 16729-009 | 16729-0009-1516729-0009-1616729-0009-17 | — |
| Pravastatin Sodium | Pravastatin sodium 40 mg/1 | TabletOral | 16729-010 | 16729-0010-1516729-0010-1616729-0010-17 | — |
| Pravastatin Sodium | Pravastatin sodium 80 mg/1 | TabletOral | 16729-011 | 16729-0011-1516729-0011-16 | — |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | 16729-278 | 16729-0278-0116729-0278-10 | — |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | 16729-279 | 16729-0279-0116729-0279-10 | — |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | 16729-280 | 16729-0280-0116729-0280-10 | — |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | 16729-281 | 16729-0281-0116729-0281-10 | — |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | 16729-282 | 16729-0282-0116729-0282-10 | — |
Accord Healthcare Inc.: common questions
- What is Accord Healthcare Inc.'s NDC labeler code?
- 16729. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Accord Healthcare Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.